NVZMY (Novonesis (Novozymes) B) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Days Payable?

Novonesis (Novozymes) B's average Accounts Payable for the three months ended in Jun. 2024 was $304 Mil. Novonesis (Novozymes) B's Cost of Goods Sold for the three months ended in Jun. 2024 was $0 Mil.

The historical rank and industry rank for Novonesis (Novozymes) B's Days Payable or its related term are showing as below:

NVZMY' s Days Payable Range Over the Past 10 Years
Min: 65.69 Med: 73.48 Max: 82.09
Current: 77.67

During the past 13 years, Novonesis (Novozymes) B's highest Days Payable was 82.09. The lowest was 65.69. And the median was 73.48.

NVZMY's Days Payable is ranked better than
64.4% of 1503 companies
in the Chemicals industry
Industry Median: 60.18 vs NVZMY: 77.67

Novonesis (Novozymes) B's Days Payable declined from Mar. 2023 (71.04) to Jun. 2024 (0.00). It may suggest that Novonesis (Novozymes) B accelerated paying its suppliers.

Novonesis (Novozymes) B Days Payable Historical Data

The historical data trend for Novonesis (Novozymes) B's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Days Payable Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

73.05

62.70

77.11

79.20

76.56

Novonesis (Novozymes) B Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															71.04	66.84	62.20	64.76	-

Competitive Comparison of Novonesis (Novozymes) B's Days Payable

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's Days Payable Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Days Payable distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Days Payable falls into.

Novonesis (Novozymes) B Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Novonesis (Novozymes) B's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (265.722	+	236.699)	/	2 )	/	1197.704	*	365
=	251.2105					/	1197.704	*	365
=	76.56

Novonesis (Novozymes) B's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (236.699	+	372.228)	/	2 )	/	0	*	365 / 4
=	304.4635					/	0	*	365 / 4
=	N/A

Novonesis (Novozymes) B Days Payable Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.